MEGESTROL ACETATE IMPURITY B
Malignant Mesothelioma
St. Vincent Medical Center - Los AngelesSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
29 Active assets in the Malignant Mesothelioma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Mayo Clinic | Phase 2 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II Dr Jean Yannis PERENTES | Phase 2 | BB |
Cyclophosphamide M.D. Anderson Cancer Center | Phase 2 | BB |
Sargramostim Memorial Sloan Kettering Cancer Center | Phase 2 | BB |
Alpha-Interferon St. Vincent Medical Center - Los Angeles | Phase 2 | B |
View all 50 →
Same molecule, other indications
MEGESTROL ACETATE IMPURITY B is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →